ACOX1 Antibodies

Santa Cruz Biotechnology provides a broad selection of ACOX1 monoclonal antibodies for research focused on understanding acyl-CoA oxidase 1. ACOX1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ACOX1 is a key enzyme in the peroxisomal beta-oxidation pathway, responsible for the initial step in the metabolism of very long-chain fatty acids. Its proper function is crucial for lipid metabolism and energy homeostasis, and dysregulation of ACOX1 has been implicated in metabolic disorders and various diseases. Understanding the expression and activity of ACOX1 can provide valuable insights into these conditions and aid in the development of therapeutic strategies. ACOX1 monoclonal antibodies enable precise detection and quantification of ACOX1 expression levels across different tissue types and experimental conditions. Researchers studying metabolic pathways can utilize ACOX1 monoclonal antibodies to examine enzyme localization and interactions with other cellular components. Advanced research techniques incorporating ACOX1 monoclonal antibodies help reveal new aspects of fatty acid metabolism regulation. Santa Cruz Biotechnology monoclonal antibodies support the scientific community in advancing our understanding of metabolic processes and potential therapeutic interventions.